Casdin Capital’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $28.9M | Hold |
|
|||||
|
2024
Q4 | $28.5M | Hold |
|
|||||
|
2024
Q3 | $30.2M | Hold |
|
|||||
|
2024
Q2 | $35.2M | Hold |
|
|||||
|
2024
Q1 | $31M | Hold |
|
|||||
|
2023
Q4 | $30.1M | Sell |
|
|||||
|
2023
Q3 | $18.7M | Sell |
|
|||||
|
2023
Q2 | $39.2M | Sell |
|
|||||
|
2023
Q1 | $30.1M | Sell |
|
|||||
|
2022
Q4 | $64.7M | Sell |
|
|||||
|
2022
Q3 | $112M | Buy |
|
|||||
|
2022
Q2 | $58.1M | Sell |
|
|||||
|
2022
Q1 | $99M | Hold |
|
|||||
|
2021
Q4 | $166M | Hold |
|
|||||
|
2021
Q3 | $159M | Hold |
|
|||||
|
2021
Q2 | $136M | Hold |
|
|||||
|
2021
Q1 | $151M | Hold |
|
|||||
|
2020
Q4 | $174M | Hold |
|
|||||
|
2020
Q3 | $144M | Hold |
|
|||||
|
2020
Q2 | $121M | Hold |
|
|||||
|
2020
Q1 | $90.6M | Buy |
|
|||||
|
2019
Q4 | $75.3M | Hold |
|
|||||
|
2019
Q3 | $69.1M | Hold |
|
|||||
|
2019
Q2 | $88.7M | Buy |
|
|||||
|
2019
Q1 | $67.9M | Buy |
|
|||||
|
2018
Q4 | $34.5M | Sell |
|
|||||
|
2018
Q3 | $58.5M | Buy |
|
|||||
|
2018
Q2 | $40.3M | Buy |
|
|||||
|
2018
Q1 | $31.9M | Hold |
|
|||||
|
2017
Q4 | $26.2M | Buy |
|
|||||
|
2017
Q3 | $20.8M | Buy |
|
|||||
|
2017
Q2 | $13.9M | Sell |
|
|||||
|
2017
Q1 | $11.8M | Buy |
|
|||||
|
2016
Q4 | $6.86M | Sell |
|
|||||
|
2016
Q3 | $8.52M | Sell |
|
|||||
|
2016
Q2 | $6.88M | Buy |
|
|||||
|
2016
Q1 | $5.8M | Sell |
|
|||||
|
2015
Q4 | $10.9M | Buy |
|